Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Turco

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Critical Reviews in Oncology/Hematology|November 25, 2022
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factorsMarco Donatello Delcuratolo, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology|April 14, 2022
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?Marco Audisio, Marcello Tucci, Rosario Francesco Di Stefano, et al.
International Journal of Molecular Sciences|January 11, 2025
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer StagesMartino Pedrani, Jessica Barizzi, Giuseppe Salfi, et al.
Research and Reports in Urology|January 26, 2023
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?Fabio Turco, Lavinia Di Prima, Chiara Pisano, et al.
European Urology Open Science|December 6, 2024
Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence StudyGiuseppe Salfi, Martino Pedrani, Selin Candan, et al.
European Urology Oncology|May 4, 2024
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysisMartino Pedrani, Giuseppe Salfi, Sara Merler, et al.
International Journal of Molecular Sciences|June 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive SettingMartino Pedrani, Giuseppe Salfi, Sara Merler, et al.
Cancers|December 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early VariationsGiuseppe Salfi, Martino Pedrani, Amos Colombo, et al.
Tumori|April 1, 2022
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysisFabio Turco, Marcello Tucci, Tiziana Angusti, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Efficacy and Safety of <i>Acmella oleracea</i> and <i>Boswellia serrata</i> Extract as Add-On Therapy for Chronic Low Back Pain: An Observational, Real-World Cohort StudyMariateresa Giglio, Consalvo Mattia, Pasquale Sansone, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|November 25, 2022
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factorsMarco Donatello Delcuratolo, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology|April 14, 2022
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?Marco Audisio, Marcello Tucci, Rosario Francesco Di Stefano, et al.
International Journal of Molecular Sciences|January 11, 2025
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer StagesMartino Pedrani, Jessica Barizzi, Giuseppe Salfi, et al.
Research and Reports in Urology|January 26, 2023
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?Fabio Turco, Lavinia Di Prima, Chiara Pisano, et al.
European Urology Open Science|December 6, 2024
Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence StudyGiuseppe Salfi, Martino Pedrani, Selin Candan, et al.
European Urology Oncology|May 4, 2024
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysisMartino Pedrani, Giuseppe Salfi, Sara Merler, et al.
International Journal of Molecular Sciences|June 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive SettingMartino Pedrani, Giuseppe Salfi, Sara Merler, et al.
Cancers|December 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early VariationsGiuseppe Salfi, Martino Pedrani, Amos Colombo, et al.
Tumori|April 1, 2022
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysisFabio Turco, Marcello Tucci, Tiziana Angusti, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Efficacy and Safety of <i>Acmella oleracea</i> and <i>Boswellia serrata</i> Extract as Add-On Therapy for Chronic Low Back Pain: An Observational, Real-World Cohort StudyMariateresa Giglio, Consalvo Mattia, Pasquale Sansone, et al.
Pageof 9